Screener
Organogenesis Holdings Inc. ORGO Grant — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Net product revenue | $42,805 | $100,779 | $79,055 | $187,472 |
| Grant income | 950 | 226 | 1,928 | 226 |
| Total revenue | 43,755 | 101,005 | 80,983 | 187,698 |
| Operating expenses: | ||||
| Cost of goods sold | 23,673 | 27,630 | 49,445 | 51,353 |
| Selling, general and administrative | 53,965 | 73,810 | 119,151 | 146,319 |
| Research and development | 18,297 | 10,395 | 33,458 | 21,035 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is Organogenesis Holdings Inc.'s grant — revenue?
- Organogenesis Holdings Inc. (ORGO) reported grant — revenue of $950K in Q2 2026.
- How has Organogenesis Holdings Inc.'s grant — revenue changed year-over-year?
- Organogenesis Holdings Inc.'s grant — revenue increased by 320.4% year-over-year, from $226K to $950K.
- What does grant — revenue mean?
- This metric represents the total revenue recognized from government or private research grants specifically allocated to the company's regenerative medicine development programs. It reflects the company's ability to secure non-dilutive funding to support innovation and clinical research activities within its specialized product segments. Tracking this revenue helps investors assess the external validation of the company's R&D pipeline and its success in leveraging external capital for product development.
Ask your AI about Organogenesis Holdings Inc.'s grant — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude